Bio

Peter is a qualified and practicing medical doctor, clinical scientist and Professor. He holds MB.ChB, MPH and PhD. He is a Senior Research Fellow with EDCTP and a Fellow of Uganda National Academy of Sciences (FUNAS). His experience spans 25 years of highly productive clinical and academic career. He is a Professor at Busitema University and a founding Executive Director of a progressive Mbale Clinical Research Institute [MCRI, http://www.mcri.ac.ug] in Eastern Uganda. In addition, he is a Visiting Professor at The Open University in UK, and Clinical Adjunct Professor at the University of Wisconsin-Madison, USA. He is ranked among the top 25 out of 500 researchers in Uganda (https://mulengeranews.com/wp-content/uploads/2022/05/uganda-top-scientists-Edited.pdf).

See more

Current Work

He has held grants as either PI or co-investigator investigating major public health conditions in Eastern Uganda including the Joint Global Health Trials (UK MRC, DFID, Wellcome) funded pneumonia trial (COAST, ISRCTN15622505), MRC funded PKPD of azithromycin in severe malaria bacterial co-infection in African children (TABS- PKPD, ISRCTN49726849), nutritional study (MIMBLE, ISRCTN 10309022), NIH funded sickle cell trial (REACH, NCT01966731), malaria studies (MEPIE Study, TMA2016SF1514), and Uganda Government funded COVID-19 studies. He has co-authored in over 130 publications of which 89 are indexed in PUBMED including 5 in the New England Journal of Medicine; [https://www.ncbi.nlm.nih.gov/pubmed/?term=Olupot-Olupot]. His current focus is on emerging and re-emerging infectious diseases on which he has furthered work on malaria research including severe malaria spectrum, malaria related acute kidney injury, COVID-19, Ebola virus disease among others. In addition, he does epidemiological research on haematological disorders and their co-morbidities.

See more

Recent publications

Is fat mass a better predictor of 6-month survival than muscle mass among African children aged 6-59 months with severe pneumonia?.
Nalwanga, D., Musiime, V., Kiguli, S., Olupot-Olupot, P., Alaroker, F., Opoka, R., Tagoola, A., Mnjalla, H., Mogaka, C., Nabawanuka, E., Giallongo, E., Karamagi, C., Briend, A., Maitland, K.
BMC Nutr, (2024). 10:130

Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.
Connon, R., Olupot-Olupot, P., Pistorius, A. M. A., Okiror, W., Ssenyondo, T., Muhindo, R., Uyoga, S., Mpoya, A., Williams, T. N., Gibb, D. M., Walker, A. S., Ter Heine, R., George, E. C., Maitland, K.
BMC Med, (2024). 22:516

Legume-supplemented feed for children hospitalised with severe malnutrition: A Phase II trial.
Walsh, K., Kiosia, A., Olupot-Oupot, P., Alaroker, F., Okiror, W., Nakuya, M., Ssenyondo, T., Amorut, D., Okalebo, C. B., Muhindo, R., Mpoya, A., George, E. C., Frost, G., Maitland, K.
Br J Nutr, (2024). 132:372-381

Nutritional supplementation in children with severe pneumonia in Uganda and Kenya (COAST-Nutrition): a phase 2 randomised controlled trial.
Kiguli, S., Olupot-Olupot, P., Hamaluba, M., Giallongo, E., Thomas, K., Alaroker, F., Opoka, R. O., Tagoola, A., Oyella, S., Nalwanga, D., Nabawanuka, E., Okiror, W., Nakuya, M., Amorut, D., Muhindo, R., Mpoya, A., Mnjalla, H., Oguda, E., Williams, T. N., Harrison, D. A., Rowan, K., Briend, A., Maitland, K.
EClinicalMedicine, (2024). 72:102640

Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial.
Aygun, B., Lane, A., Smart, L. R., Santos, B., Tshilolo, L., Williams, T. N., Olupot-Olupot, P., Stuber, S. E., Tomlinson, G., Latham, T., Ware, R. E.
Lancet Haematol, (2024). 11:e425-e435